Clinical Trials Directory

Trials / Completed

CompletedNCT02567110

Magnetic Resonance Spectroscopy (MRS) in Midlife Depression

Inflammation-Induced Central Nervous System (CNS) Glutamate as a Function of Depression in Middle Age

Status
Completed
Phase
Study type
Observational
Enrollment
169 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the impact of inflammation on central nervous system (CNS) glutamate, white matter pathology and alterations in behavior and cognition in middle-aged patients with major depression. Depression is associated with significant alterations in glutamate concentrations and white matter integrity, which has been associated with decreased antidepressant response, poor functional outcome, and cognitive impairment.

Detailed description

This study involves behavioral assessments, neurocognitive testing, blood sampling and magnetic resonance imaging (MRI) scanning. Goals of this study are to determine the impact of inflammation on glutamate concentrations in the basal ganglia and on the integrity of white matter tracts in the basal ganglia and other subcortical regions of middle-aged depressed versus non-depressed individuals and to associated the impact of glutamate and white matter changes on behavioral symptoms among the same group of patients.

Conditions

Timeline

Start date
2016-07-01
Primary completion
2022-02-04
Completion
2022-02-04
First posted
2015-10-02
Last updated
2023-02-03

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02567110. Inclusion in this directory is not an endorsement.